We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Study: Amgen's Denosumab Increases Bone Mineral Density
Study: Amgen's Denosumab Increases Bone Mineral Density
March 8, 2006
An investigational monoclonal antibody significantly increased bone mineral density (BMD) when compared with a placebo, a Phase II trial demonstrated.